Scarica l'app Stockscreener
23.59
0.59%
-0.14
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$23.73
Aprire:
$23.59
Volume 24 ore:
96,943
Relative Volume:
0.50
Capitalizzazione di mercato:
$955.08M
Reddito:
$982.01M
Utile/perdita netta:
$14.80M
Rapporto P/E:
28.77
EPS:
0.82
Flusso di cassa netto:
$37.02M
1 W Prestazione:
+0.86%
1M Prestazione:
+0.68%
6M Prestazione:
+27.17%
1 anno Prestazione:
+127.92%
Intervallo 1D:
$23.24
$23.87
Intervallo di 1 settimana:
$23.13
$24.74
Portata 52W:
$9.49
$25.98
Phibro Animal Health Corp Stock (PAHC) Company Profile
Nome
Phibro Animal Health Corp
Settore
Telefono
201-329-7300
Indirizzo
GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ
Confronta PAHC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PAHC
Phibro Animal Health Corp
|
23.59 | 955.08M | 982.01M | 14.80M | 37.02M | 0.82 |
|
ZTS
Zoetis Inc
|
176.74 | 80.59B | 9.15B | 2.43B | 2.31B | 4.92 |
|
HLN
Haleon Plc Adr
|
9.72 | 44.17B | 14.26B | 1.55B | 0 | 0.3327 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.57 | 42.61B | 30.27B | 1.93B | 3.45B | 0.444 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.57 | 18.77B | 16.77B | -959.00M | 1.37B | -2.00 |
|
VTRS
Viatris Inc
|
13.22 | 15.73B | 15.05B | -883.30M | 1.89B | 1.53 |
Phibro Animal Health Corp Stock (PAHC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-09-10 | Iniziato | JP Morgan | Neutral |
| 2023-12-07 | Iniziato | Exane BNP Paribas | Underperform |
| 2022-12-21 | Iniziato | ROTH Capital | Buy |
| 2022-07-25 | Downgrade | Barclays | Equal Weight → Underweight |
| 2022-01-10 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2021-11-18 | Iniziato | Morgan Stanley | Equal-Weight |
| 2021-08-05 | Ripresa | Credit Suisse | Neutral |
| 2021-07-07 | Downgrade | Barclays | Equal Weight → Underweight |
| 2020-08-06 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2020-02-06 | Downgrade | Gabelli & Co | Buy → Hold |
| 2020-01-28 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2019-09-05 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2019-08-29 | Reiterato | BofA/Merrill | Underperform |
| 2019-06-11 | Iniziato | Barclays | Underweight |
| 2019-05-23 | Iniziato | Guggenheim | Neutral |
| 2019-05-09 | Aggiornamento | Gabelli & Co | Hold → Buy |
| 2017-08-23 | Ripresa | BofA/Merrill | Underperform |
| 2017-06-02 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2016-12-15 | Iniziato | Piper Jaffray | Overweight |
| 2016-11-11 | Downgrade | Macquarie | Neutral → Underperform |
| 2016-11-10 | Downgrade | Gabelli & Co | Buy → Hold |
| 2016-04-11 | Reiterato | Guggenheim | Buy |
| 2016-02-04 | Iniziato | Credit Suisse | Outperform |
| 2016-01-15 | Downgrade | Barclays | Overweight → Underweight |
| 2015-09-30 | Iniziato | Gabelli & Co | Buy |
| 2015-04-24 | Reiterato | Barclays | Overweight |
| 2015-04-21 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2014-05-06 | Iniziato | Barclays | Overweight |
Mostra tutto
Phibro Animal Health Corp Borsa (PAHC) Ultime notizie
PAHC (Phibro Animal Health) 5-Year Dividend Growth Rate : 0.60% (As of Sep. 2024) - GuruFocus.com
PAHC (Phibro Animal Health) Free Cash Flow per Share : $1.00 (TTM As of Sep. 2024) - GuruFocus.com
PAHC (Phibro Animal Health) Effective Interest Rate on Debt % : 6.30% (As of Sep. 2024) - GuruFocus.com
Why Phibro Animal Health (PAHC) is a Top Momentum Stock for the Long-Term - Yahoo Finance Australia
PAHC (Phibro Animal Health) EPS without NRI : $1.40 (TTM As of Sep. 2024) - GuruFocus.com
Zacks Research Has Pessimistic Outlook of PAHC Q3 Earnings - MarketBeat
PAHC (Phibro Animal Health) 50-Day SMA : $23.16 (As of Nov. 24, 2024) - GuruFocus.com
Atria Investments Inc Has $283,000 Position in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
PAHC (Phibro Animal Health) FCF Margin % : 1.17% (As of Sep. 2024) - GuruFocus.com
Zacks Research Has Pessimistic Outlook of PAHC Q2 Earnings - MarketBeat
Should Value Investors Buy Phibro Animal Health (PAHC) Stock? - Yahoo Finance
Phibro Animal Health (NASDAQ:PAHC) Lowered to Buy Rating by StockNews.com - MarketBeat
Phibro Animal Health (NASDAQ:PAHC) Has Affirmed Its Dividend Of $0.12 - Yahoo Finance
Phibro Animal Health Corp (PAHC) Shares Gap Down to $24.34 on No - GuruFocus.com
Phibro Animal Health Corporation Updates Standalone Financial Guidance for Fiscal Year Ending June 30, 2025 and Provides Preliminary Financial Guidance for the Eight Months in Fiscal Year 2025 - Marketscreener.com
There May Be Some Bright Spots In Phibro Animal Health's (NASDAQ:PAHC) Earnings - Yahoo Finance
Phibro Animal Health Corporation Announces Executive Changes - Marketscreener.com
Looking for a Growth Stock? 3 Reasons Why Phibro (PAHC) is a Solid Choice - Yahoo Finance
Barclays Issues Positive Forecast for Phibro Animal Health (NASDAQ:PAHC) Stock Price - MarketBeat
Phibro Animal Health Corporation (PAHC) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
Phibro Anim stock soars to 52-week high, hits $25.2 By Investing.com - Investing.com South Africa
Phibro Anim stock soars to 52-week high, hits $25.2 - Investing.com
Investing in Phibro (PAHC)? Don't Miss Assessing Its International Revenue Trends - Yahoo Finance
Phibro Animal Health Corporation (NASDAQ:PAHC) Q1 2025 Earnings Call Transcript - Insider Monkey
Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock - Yahoo Finance
Phibro Animal Health First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Phibro Animal Health Corp (PAHC) Q1 2025 Earnings Call Highlights: Strong Sales Growth and Strategic Acquisitions - GuruFocus.com
Phibro Animal Health Corp (PAHC) Q1 2025 Earnings Call Highlights: Strong Sales Growth and ... - Yahoo Finance UK
Phibro Animal Health Reports Strong Q1 Performance - TipRanks
Phibro Animal Health Co. (NASDAQ:PAHC) to Issue Quarterly Dividend of $0.12 - MarketBeat
Phibro's Q1 Earnings Top Estimates, Stock Up, Net Sales Surge Y/Y - Yahoo Finance Australia
Zacks.com featured highlights include IAMGOLD, Leidos, Brinker International, Phibro Animal Health and State Street - Yahoo Finance
Phibro Animal Health Corp (PAHC) Q1 Earnings: EPS of $0.17 Beats Estimates, Revenue Surges to $260.4 Million - GuruFocus.com
Phibro: Fiscal Q1 Earnings Snapshot - San Francisco Chronicle
Phibro Animal Health (PAHC) Tops Q1 Earnings Estimates - Yahoo Finance
Phibro Animal Health Corporation Reports First Quarter Results, Updates Financial Guidance - StockTitan
Phibro Animal Health Corporation Reports Earnings Results for the First Quarter Ended September 30, 2024 - Marketscreener.com
What To Expect From Phibro Animal Health Corp (PAHC) Q1 2025 Ear - GuruFocus.com
What To Expect From Phibro Animal Health Corp (PAHC) Q1 2025 Earnings - Yahoo Finance
Phibro Animal Health Corporation Declares Quarterly Dividend - StockTitan
Phibro announces quarterly dividend of $0.12 per share - Investing.com
What's Next: Phibro Animal Health's Earnings Preview - Benzinga
Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now? - Yahoo Finance
Phibro Animal Health Corp (PAHC) Q1 2025 Earnings Report Preview: What to Expect - GuruFocus.com
Vanguard Group Inc's Strategic Acquisition in Phibro Animal Heal - GuruFocus.com
Should We Be Cautious About Phibro Animal Health Corporation's (NASDAQ:PAHC) ROE Of 0.9%? - Yahoo Finance
Phibro completes acquisition of Zoetis’ medicated feed additive business - FeedStrategy.com
PAHC Stock Likely to Gain From Its Latest Acquisition of Zoetis - Yahoo Finance
Phibro Animal Health Corporation Completes Acquisition of Zoetis’ Medicated Feed Additive Product Portfolio and Certain Water-Soluble Products - Yahoo Finance
Phibro Animal Health (PAHC) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
Phibro Animal Health (PAHC) Set to Announce Earnings on Wednesday - MarketBeat
Phibro Animal Health Corp Azioni (PAHC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.83%
1.03%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):